| Financial Year |
March 31 2023 |
| Monetary Funds |
33,047,750.62 |
| Held-for-trading Financial Assets |
80,105,956.05 |
| Notes Receivable |
52,605,254.67 |
| Accounts Receivable |
208,421,191.37 |
| Advances to Suppliers |
11,038,529.53 |
| Other Receivables |
1,977,697.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,444,128.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,226,082.78 |
| Total Current Assets |
510,823,350.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
41,965,747.37 |
| Under-construction Projects |
161,308,408.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,997,393.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
683,987.67 |
| Deferred Income Tax Assets |
11,942,672.00 |
| Other Non-Current Assets |
12,121,191.28 |
| Sub-Total of Non-Current Assets |
271,019,400.41 |
| Total Assets |
781,842,750.90 |
| Short-Term Loans |
28,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,155,176.10 |
| Accounts Payable |
86,853,957.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,070,563.86 |
| Taxes Payable |
740,140.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,371,709.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
39,486,162.28 |
| Sub-Total of Current Liabilities |
181,891,711.17 |
| Long-term Loans |
84,030,660.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,894,514.05 |
| Deferred Income Tax Liabilities |
176,500.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
111,002,890.15 |
| Total Liabilities |
292,894,601.32 |
| Paid-In Capital(Or Share Stock) |
83,893,334.00 |
| Capital Surplus |
217,550,367.63 |
| Surplus Reserve |
36,432,428.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
151,072,019.30 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
488,948,149.58 |
| Owner's Equity（Stockholder's Equity） |
488,948,149.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
781,842,750.90 |
